318 related articles for article (PubMed ID: 35361533)
1. Immune Cells in Pulmonary Arterial Hypertension.
Ni S; Ji T; Dong J; Chen F; Feng H; Zhao H; Chen D; Ma W
Heart Lung Circ; 2022 Jul; 31(7):934-943. PubMed ID: 35361533
[TBL] [Abstract][Full Text] [Related]
2. Blockade of JAK2 protects mice against hypoxia-induced pulmonary arterial hypertension by repressing pulmonary arterial smooth muscle cell proliferation.
Zhang L; Wang Y; Wu G; Rao L; Wei Y; Yue H; Yuan T; Yang P; Xiong F; Zhang S; Zhou Q; Chen Z; Li J; Mo BW; Zhang H; Xiong W; Wang CY
Cell Prolif; 2020 Feb; 53(2):e12742. PubMed ID: 31943454
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of Hsp110-STAT3 interaction in endothelial cells alleviates vascular remodeling in hypoxic pulmonary arterial Hypertension model.
Zhao C; Le X; Li M; Hu Y; Li X; Chen Z; Hu G; Hu L; Li Q
Respir Res; 2023 Nov; 24(1):289. PubMed ID: 37978368
[TBL] [Abstract][Full Text] [Related]
4. JAGGED-NOTCH3 signaling in vascular remodeling in pulmonary arterial hypertension.
Zhang Y; Hernandez M; Gower J; Winicki N; Morataya X; Alvarez S; Yuan JX; Shyy J; Thistlethwaite PA
Sci Transl Med; 2022 May; 14(643):eabl5471. PubMed ID: 35507674
[TBL] [Abstract][Full Text] [Related]
5. New progress in diagnosis and treatment of pulmonary arterial hypertension.
Zhang ZQ; Zhu SK; Wang M; Wang XA; Tong XH; Wan JQ; Ding JW
J Cardiothorac Surg; 2022 Aug; 17(1):216. PubMed ID: 36038916
[TBL] [Abstract][Full Text] [Related]
6. [New insights in the pathogenesis of pulmonary arterial hypertension].
Bordenave J; Tu L; Savale L; Huertas A; Humbert M; Guignabert C
Rev Mal Respir; 2019 Apr; 36(4):433-437. PubMed ID: 31010759
[TBL] [Abstract][Full Text] [Related]
7. LncRNA-SMILR modulates RhoA/ROCK signaling by targeting miR-141 to regulate vascular remodeling in pulmonary arterial hypertension.
Lei S; Peng F; Li ML; Duan WB; Peng CQ; Wu SJ
Am J Physiol Heart Circ Physiol; 2020 Aug; 319(2):H377-H391. PubMed ID: 32559140
[TBL] [Abstract][Full Text] [Related]
8. Novel Molecular Mechanisms Involved in the Medical Treatment of Pulmonary Arterial Hypertension.
Martin de Miguel I; Cruz-Utrilla A; Oliver E; Escribano-Subias P
Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36835558
[TBL] [Abstract][Full Text] [Related]
9. TUG1 Regulates Pulmonary Arterial Smooth Muscle Cell Proliferation in Pulmonary Arterial Hypertension.
Wang S; Cao W; Gao S; Nie X; Zheng X; Xing Y; Chen Y; Bao H; Zhu D
Can J Cardiol; 2019 Nov; 35(11):1534-1545. PubMed ID: 31679623
[TBL] [Abstract][Full Text] [Related]
10. Nestin represents a potential marker of pulmonary vascular remodeling in pulmonary arterial hypertension associated with congenital heart disease.
Zhou JJ; Li H; Qian YL; Quan RL; Chen XX; Li L; Li Y; Wang PH; Meng XM; Jing XL; He JG
J Mol Cell Cardiol; 2020 Dec; 149():41-53. PubMed ID: 32950539
[TBL] [Abstract][Full Text] [Related]
11. Inflammation in Pulmonary Arterial Hypertension.
Klouda T; Yuan K
Adv Exp Med Biol; 2021; 1303():351-372. PubMed ID: 33788202
[TBL] [Abstract][Full Text] [Related]
12. Single-Cell Imaging Maps Inflammatory Cell Subsets to Pulmonary Arterial Hypertension Vasculopathy.
Ferrian S; Cao A; McCaffrey EF; Saito T; Greenwald NF; Nicolls MR; Bruce T; Zamanian RT; Del Rosario P; Rabinovitch M; Angelo M
Am J Respir Crit Care Med; 2024 Jan; 209(2):206-218. PubMed ID: 37934691
[No Abstract] [Full Text] [Related]
13. Molecular mechanisms of pulmonary arterial remodeling.
Crosswhite P; Sun Z
Mol Med; 2014 Apr; 20(1):191-201. PubMed ID: 24676136
[TBL] [Abstract][Full Text] [Related]
14. Multicenter Preclinical Validation of BET Inhibition for the Treatment of Pulmonary Arterial Hypertension.
Van der Feen DE; Kurakula K; Tremblay E; Boucherat O; Bossers GPL; Szulcek R; Bourgeois A; Lampron MC; Habbout K; Martineau S; Paulin R; Kulikowski E; Jahagirdar R; Schalij I; Bogaard HJ; Bartelds B; Provencher S; Berger RMF; Bonnet S; Goumans MJ
Am J Respir Crit Care Med; 2019 Oct; 200(7):910-920. PubMed ID: 31042405
[No Abstract] [Full Text] [Related]
15. Prostaglandin and prostaglandin receptors: present and future promising therapeutic targets for pulmonary arterial hypertension.
Zeng C; Liu J; Zheng X; Hu X; He Y
Respir Res; 2023 Nov; 24(1):263. PubMed ID: 37915044
[TBL] [Abstract][Full Text] [Related]
16. Central role of ubiquitin-specific protease 8 in leptin signaling pathway in pulmonary arterial hypertension.
Jutant EM; Chelgham MK; Ottaviani M; Thuillet R; Le Vely B; Humbert M; Guignabert C; Tu L; Huertas A
J Heart Lung Transplant; 2024 Jan; 43(1):120-133. PubMed ID: 37704159
[TBL] [Abstract][Full Text] [Related]
17. Potential of the TRPM7 channel as a novel therapeutic target for pulmonary arterial hypertension.
Hiraishi K; Kurahara LH; Ishikawa K; Go T; Yokota N; Hu Y; Fujita T; Inoue R; Hirano K
J Smooth Muscle Res; 2022; 58(0):50-62. PubMed ID: 35944979
[TBL] [Abstract][Full Text] [Related]
18. Loss of DP1 Aggravates Vascular Remodeling in Pulmonary Arterial Hypertension via mTORC1 Signaling.
He Y; Zuo C; Jia D; Bai P; Kong D; Chen D; Liu G; Li J; Wang Y; Chen G; Yan S; Xiao B; Zhang J; Piao L; Li Y; Deng Y; Li B; Roux PP; Andreasson KI; Breyer RM; Su Y; Wang J; Lyu A; Shen Y; Yu Y
Am J Respir Crit Care Med; 2020 May; 201(10):1263-1276. PubMed ID: 31917615
[No Abstract] [Full Text] [Related]
19. Pathobiology of pulmonary artery hypertension: role of long non-coding RNAs.
Zahid KR; Raza U; Chen J; Raj UJ; Gou D
Cardiovasc Res; 2020 Oct; 116(12):1937-1947. PubMed ID: 32109276
[TBL] [Abstract][Full Text] [Related]
20. NMDA-Type Glutamate Receptor Activation Promotes Vascular Remodeling and Pulmonary Arterial Hypertension.
Dumas SJ; Bru-Mercier G; Courboulin A; Quatredeniers M; Rücker-Martin C; Antigny F; Nakhleh MK; Ranchoux B; Gouadon E; Vinhas MC; Vocelle M; Raymond N; Dorfmüller P; Fadel E; Perros F; Humbert M; Cohen-Kaminsky S
Circulation; 2018 May; 137(22):2371-2389. PubMed ID: 29444988
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
